| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 6.87e-05 | 2 | 166 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 6.87e-05 | 2 | 166 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.52e-04 | 13 | 166 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.39e-04 | 15 | 166 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.92e-04 | 16 | 166 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.92e-04 | 16 | 166 | 3 | GO:0050543 | |
| GeneOntologyBiologicalProcess | cilium organization | GBF1 TTC21A RTTN STIL ARMC2 FSIP2 CFAP54 TBC1D1 CBY1 CEP250 IQCB1 TEKT1 TEKT4 ATXN10 SGSM3 CCDC63 CFAP46 PCNT | 5.41e-08 | 476 | 165 | 18 | GO:0044782 |
| GeneOntologyBiologicalProcess | organelle assembly | KNTC1 GBF1 RTTN RNF213 STIL ARMC2 TUBGCP6 FSIP2 CFAP54 MDN1 AP1B1 ARHGEF10 EHMT2 PIK3C3 TBC1D1 CBY1 CEP250 IQCB1 TEKT1 TEKT4 ATXN10 ATM SGSM3 CCDC63 KIF11 CFAP46 PCNT | 3.66e-07 | 1138 | 165 | 27 | GO:0070925 |
| GeneOntologyBiologicalProcess | cilium assembly | GBF1 STIL ARMC2 FSIP2 CFAP54 TBC1D1 CBY1 CEP250 IQCB1 TEKT1 TEKT4 ATXN10 SGSM3 CCDC63 CFAP46 PCNT | 5.89e-07 | 444 | 165 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | BICDL2 MYO5A ING2 TTC21A RTTN STIL ARMC2 LYST ADCY3 KIF20A TUBGCP6 FSIP2 BICDL1 CFAP54 ARHGEF10 CEP250 TTLL4 TEKT1 MACF1 TEKT4 DIXDC1 CCDC63 KIF11 CFAP46 PCNT | 1.13e-06 | 1058 | 165 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | GBF1 P2RY12 WHAMM STIL ARMC2 FSIP2 CFAP54 TBC1D1 CBY1 CEP250 IQCB1 TEKT1 TEKT4 ATXN10 SGSM3 ARHGEF4 CCDC63 CFAP46 PCNT | 1.85e-06 | 670 | 165 | 19 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | GBF1 P2RY12 WHAMM STIL ARMC2 FSIP2 CFAP54 TBC1D1 CBY1 CEP250 IQCB1 TEKT1 TEKT4 ATXN10 SGSM3 ARHGEF4 CCDC63 CFAP46 PCNT | 2.55e-06 | 685 | 165 | 19 | GO:0030031 |
| GeneOntologyBiologicalProcess | microtubule-based movement | BICDL2 MYO5A ING2 TTC21A ARMC2 ADCY3 KIF20A FSIP2 BICDL1 CFAP54 TEKT1 TEKT4 CCDC63 KIF11 CFAP46 | 1.05e-05 | 493 | 165 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | negative regulation of response to type II interferon | 2.73e-05 | 8 | 165 | 3 | GO:0060331 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon-mediated signaling pathway | 2.73e-05 | 8 | 165 | 3 | GO:0060336 | |
| GeneOntologyBiologicalProcess | cilium movement | ING2 TTC21A ARMC2 ADCY3 FSIP2 CFAP54 TEKT1 TEKT4 CCDC63 CFAP46 | 4.96e-05 | 261 | 165 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 5.04e-05 | 210 | 165 | 9 | GO:0060294 | |
| GeneOntologyBiologicalProcess | secretion of lysosomal enzymes | 5.79e-05 | 10 | 165 | 3 | GO:0033299 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 6.04e-05 | 215 | 165 | 9 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 6.04e-05 | 215 | 165 | 9 | GO:0001539 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.45e-04 | 99 | 165 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.53e-04 | 100 | 165 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | Golgi to secretory granule transport | 1.90e-04 | 3 | 165 | 2 | GO:0055107 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 1.90e-04 | 3 | 165 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | regulation of secretion of lysosomal enzymes | 1.90e-04 | 3 | 165 | 2 | GO:0090182 | |
| GeneOntologyBiologicalProcess | cell cycle process | KNTC1 ING2 TTI2 RTTN USP29 STIL TEX11 TRRAP PABIR3 KIF20A FANCD2 TUBGCP6 USP26 TLK1 ARHGEF10 EHMT2 PIK3C3 CEP250 MMS19 ATXN10 ATM DNA2 IQGAP3 KIF11 PCNT | 2.02e-04 | 1441 | 165 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 2.13e-04 | 15 | 165 | 3 | GO:0051791 | |
| GeneOntologyBiologicalProcess | regulation of response to type II interferon | 2.13e-04 | 15 | 165 | 3 | GO:0060330 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon-mediated signaling pathway | 2.13e-04 | 15 | 165 | 3 | GO:0060334 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 3.69e-04 | 217 | 165 | 8 | GO:0000075 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 3.94e-04 | 119 | 165 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 4.56e-04 | 45 | 165 | 4 | GO:0043001 | |
| GeneOntologyCellularComponent | cilium | NPHP1 MYO5A TTC21A RTTN LDHA ADCY3 USP26 FSIP2 CFAP54 PIK3C3 USH1G CBY1 CEP250 TTLL4 IQCB1 TEKT1 TEKT4 ATXN10 CCDC63 CFAP46 PCNT | 1.13e-05 | 898 | 168 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | microtubule organizing center | KRT18 UBR4 RTTN ANKRD62 STIL PPP4R3A TUBGCP6 BICDL1 ARHGEF10 SLC18A2 USH1G CBY1 CEP250 TTLL4 IQCB1 SLMAP MMS19 ATXN10 ATM PCNT | 5.11e-05 | 919 | 168 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | KRT18 UBR4 RTTN ANKRD62 STIL PPP4R3A TUBGCP6 BICDL1 ARHGEF10 SLC18A2 USH1G CEP250 IQCB1 SLMAP MMS19 ATM PCNT | 1.62e-04 | 770 | 168 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.86e-04 | 263 | 168 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | centriole | 4.92e-04 | 172 | 168 | 7 | GO:0005814 | |
| Domain | ARM-type_fold | GBF1 TTI2 UBR4 RTTN XPO4 HEATR1 API5 ARMC2 TRRAP LYST ELMO1 PPP4R3A ELMO3 MROH1 AP1B1 AP2B1 PIK3C3 IQCB1 MMS19 STAG3L3 ATXN10 ATM HECTD1 | 3.23e-14 | 339 | 165 | 23 | IPR016024 |
| Domain | ARM-like | TTI2 RTTN XPO4 HEATR1 API5 ARMC2 TRRAP ELMO1 PPP4R3A ELMO3 MROH1 AP1B1 AP2B1 IQCB1 MMS19 STAG3L3 ATXN10 HECTD1 | 3.17e-11 | 270 | 165 | 18 | IPR011989 |
| Domain | - | RTTN XPO4 HEATR1 API5 ARMC2 TRRAP ELMO1 MROH1 AP1B1 AP2B1 MMS19 ATXN10 HECTD1 | 9.01e-08 | 222 | 165 | 13 | 1.25.10.10 |
| Domain | Clathrin_b-adaptin_app_Ig-like | 7.76e-05 | 2 | 165 | 2 | IPR013037 | |
| Domain | Liver_X_rcpt | 7.76e-05 | 2 | 165 | 2 | IPR023257 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 2.60.40.1150 | |
| Domain | Ank | 1.98e-04 | 228 | 165 | 9 | PF00023 | |
| Domain | DUF3361 | 2.31e-04 | 3 | 165 | 2 | IPR024574 | |
| Domain | AP_complex_bsu_1_2_4 | 2.31e-04 | 3 | 165 | 2 | IPR016342 | |
| Domain | USP37-like_PH | 2.31e-04 | 3 | 165 | 2 | IPR032069 | |
| Domain | DUF3361 | 2.31e-04 | 3 | 165 | 2 | PF11841 | |
| Domain | B2-adapt-app_C | 2.31e-04 | 3 | 165 | 2 | PF09066 | |
| Domain | UCH_N | 2.31e-04 | 3 | 165 | 2 | PF16674 | |
| Domain | CH | 2.73e-04 | 65 | 165 | 5 | SM00033 | |
| Domain | - | 3.48e-04 | 16 | 165 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.48e-04 | 16 | 165 | 3 | SM00146 | |
| Domain | CH | 3.86e-04 | 70 | 165 | 5 | PF00307 | |
| Domain | ANK | 4.02e-04 | 251 | 165 | 9 | SM00248 | |
| Domain | - | 4.12e-04 | 71 | 165 | 5 | 1.10.418.10 | |
| Domain | ANK_REPEAT | 4.26e-04 | 253 | 165 | 9 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.38e-04 | 254 | 165 | 9 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.38e-04 | 254 | 165 | 9 | PS50297 | |
| Domain | Cavin_fam | 4.60e-04 | 4 | 165 | 2 | IPR026752 | |
| Domain | B2-adapt-app_C | 4.60e-04 | 4 | 165 | 2 | SM01020 | |
| Domain | PTRF_SDPR | 4.60e-04 | 4 | 165 | 2 | PF15237 | |
| Domain | B-adaptin_app_sub_C | 4.60e-04 | 4 | 165 | 2 | IPR015151 | |
| Domain | CH | 4.69e-04 | 73 | 165 | 5 | PS50021 | |
| Domain | PI3_PI4_kinase | 5.01e-04 | 18 | 165 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.01e-04 | 18 | 165 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.01e-04 | 18 | 165 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.01e-04 | 18 | 165 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.01e-04 | 18 | 165 | 3 | PS50290 | |
| Domain | CH-domain | 5.31e-04 | 75 | 165 | 5 | IPR001715 | |
| Domain | Ankyrin_rpt | 5.48e-04 | 262 | 165 | 9 | IPR002110 | |
| Domain | AP_beta | 7.62e-04 | 5 | 165 | 2 | IPR026739 | |
| Domain | ACTININ_2 | 1.05e-03 | 23 | 165 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.05e-03 | 23 | 165 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.05e-03 | 23 | 165 | 3 | IPR001589 | |
| Domain | TPR-like_helical_dom | 1.11e-03 | 233 | 165 | 8 | IPR011990 | |
| Domain | TRP_2 | 1.14e-03 | 6 | 165 | 2 | PF08344 | |
| Domain | - | 1.14e-03 | 6 | 165 | 2 | 3.90.1290.10 | |
| Domain | ELMO_CED12 | 1.14e-03 | 6 | 165 | 2 | PF04727 | |
| Domain | TRP_dom | 1.14e-03 | 6 | 165 | 2 | IPR013555 | |
| Domain | FAT | 1.14e-03 | 6 | 165 | 2 | PS51189 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | PS51190 | |
| Domain | ELMO | 1.14e-03 | 6 | 165 | 2 | PS51335 | |
| Domain | FAT | 1.14e-03 | 6 | 165 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.14e-03 | 6 | 165 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.14e-03 | 6 | 165 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.14e-03 | 6 | 165 | 2 | IPR014009 | |
| Domain | Beta2_adaptin/TBP_C_dom | 1.14e-03 | 6 | 165 | 2 | IPR012295 | |
| Domain | PH_12 | 1.14e-03 | 6 | 165 | 2 | PF16457 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | SM01343 | |
| Domain | - | 1.14e-03 | 6 | 165 | 2 | 3.30.310.10 | |
| Domain | ELMO_dom | 1.14e-03 | 6 | 165 | 2 | IPR006816 | |
| Domain | Plectin | 1.58e-03 | 7 | 165 | 2 | PF00681 | |
| Domain | TRPC_channel | 1.58e-03 | 7 | 165 | 2 | IPR002153 | |
| Domain | Plectin_repeat | 1.58e-03 | 7 | 165 | 2 | IPR001101 | |
| Domain | PLEC | 1.58e-03 | 7 | 165 | 2 | SM00250 | |
| Domain | - | 1.66e-03 | 248 | 165 | 8 | 1.25.40.20 | |
| Domain | Spectrin_repeat | 2.09e-03 | 29 | 165 | 3 | IPR002017 | |
| Domain | Coatomer/calthrin_app_sub_C | 2.10e-03 | 8 | 165 | 2 | IPR009028 | |
| Domain | Tektin | 2.10e-03 | 8 | 165 | 2 | IPR000435 | |
| Domain | A2M_N_2 | 2.10e-03 | 8 | 165 | 2 | SM01359 | |
| Domain | - | 2.10e-03 | 8 | 165 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 2.10e-03 | 8 | 165 | 2 | SM01361 | |
| Domain | A2M | 2.10e-03 | 8 | 165 | 2 | SM01360 | |
| Domain | Intermediate_filament_CS | 2.33e-03 | 63 | 165 | 4 | IPR018039 | |
| Domain | - | 2.47e-03 | 207 | 165 | 7 | 1.25.40.10 | |
| Domain | Alpha_adaptinC2 | 2.68e-03 | 9 | 165 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.68e-03 | 9 | 165 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.68e-03 | 9 | 165 | 2 | SM00809 | |
| Domain | SPEC | 2.78e-03 | 32 | 165 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.78e-03 | 32 | 165 | 3 | IPR018159 | |
| Domain | A2M | 3.33e-03 | 10 | 165 | 2 | PF00207 | |
| Domain | A2M_N_2 | 3.33e-03 | 10 | 165 | 2 | IPR011625 | |
| Domain | A2M_comp | 3.33e-03 | 10 | 165 | 2 | IPR011626 | |
| Domain | A2M_recep | 3.33e-03 | 10 | 165 | 2 | PF07677 | |
| Domain | A2M_comp | 3.33e-03 | 10 | 165 | 2 | PF07678 | |
| Domain | A2M_N | 3.33e-03 | 10 | 165 | 2 | PF01835 | |
| Domain | A2M_N | 3.33e-03 | 10 | 165 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.33e-03 | 10 | 165 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.33e-03 | 10 | 165 | 2 | PS00477 | |
| Domain | A2M_N_2 | 3.33e-03 | 10 | 165 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 3.33e-03 | 10 | 165 | 2 | IPR001599 | |
| Domain | Ion_trans_dom | 3.43e-03 | 114 | 165 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.43e-03 | 114 | 165 | 5 | PF00520 | |
| Domain | Filament | 3.60e-03 | 71 | 165 | 4 | SM01391 | |
| Domain | IF | 3.79e-03 | 72 | 165 | 4 | PS00226 | |
| Domain | Filament | 3.98e-03 | 73 | 165 | 4 | PF00038 | |
| Domain | TRP_channel | 4.05e-03 | 11 | 165 | 2 | IPR004729 | |
| Domain | IF | 4.60e-03 | 76 | 165 | 4 | IPR001664 | |
| Domain | Coatomer/clathrin_app_Ig-like | 4.83e-03 | 12 | 165 | 2 | IPR013041 | |
| Domain | - | 4.83e-03 | 12 | 165 | 2 | 1.50.10.20 | |
| Domain | ARM | 5.26e-03 | 40 | 165 | 3 | SM00185 | |
| Domain | OLF | 5.68e-03 | 13 | 165 | 2 | PF02191 | |
| Domain | OLF | 5.68e-03 | 13 | 165 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 5.68e-03 | 13 | 165 | 2 | IPR003112 | |
| Domain | OLF | 5.68e-03 | 13 | 165 | 2 | SM00284 | |
| Domain | IQ | 5.77e-03 | 81 | 165 | 4 | SM00015 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 GBF1 MFHAS1 PIEZO1 UBR4 RTTN SMG5 ANKHD1 TRRAP LYST AHDC1 TLK1 MDN1 MROH1 FANCI TTLL4 TANC1 ARHGEF4 HECTD1 IQGAP3 CREB3 PCNT KLHL17 | 5.40e-09 | 1105 | 170 | 23 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 KRT18 DSP GIGYF1 STIL LYST FSIP2 MDN1 ARHGEF10 PIK3C3 CLMN TBC1D1 RABGAP1L IQCB1 MACF1 TANC1 ARHGEF4 HECTD1 TMCC1 KIF11 | 9.60e-09 | 861 | 170 | 20 | 36931259 |
| Pubmed | GBF1 MYO5A UBR4 EI24 RNF213 HEATR1 API5 PARP14 LDHA ADCY3 ELMO1 TUBGCP6 MDN1 AP2B1 INTS2 PIK3C3 FANCI ADGRE5 MMS19 ATXN10 DNAJC1 KIF11 PCNT | 1.51e-08 | 1168 | 170 | 23 | 19946888 | |
| Pubmed | 3.20e-08 | 187 | 170 | 10 | 26460568 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | NPHP1 KRT72 KNTC1 KRT13 KRT18 MYO5A DSP KRT33B ANKHD1 LDHA MROH1 IQCB1 MMS19 ATXN10 IQGAP3 | 1.36e-07 | 564 | 170 | 15 | 21565611 |
| Pubmed | MYO5A DSP UBR4 HEATR1 ANKHD1 TRRAP DDX10 S100A8 MDN1 AP1B1 AP2B1 FANCI MACF1 ATM HECTD1 PCNT | 1.54e-07 | 653 | 170 | 16 | 22586326 | |
| Pubmed | GBF1 DSP COPE UBR4 HEATR1 ANKHD1 MDN1 AP1B1 FANCI IQCB1 ATXN10 | 2.00e-07 | 288 | 170 | 11 | 23383273 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 35810773 | ||
| Pubmed | Cholestenoic acids regulate motor neuron survival via liver X receptors. | 4.57e-07 | 4 | 170 | 3 | 25271621 | |
| Pubmed | FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. | 4.57e-07 | 4 | 170 | 3 | 18931676 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 9707615 | ||
| Pubmed | KRT72 KNTC1 KRT13 KRT18 MYO5A DSP KRT33B UBR4 HEATR1 PNISR LYST TLK1 MDN1 AP2B1 MACF1 PABPC1L ATM ARHGEF4 POLQ CAVIN2 KIF11 CFAP46 PCNT | 6.40e-07 | 1442 | 170 | 23 | 35575683 | |
| Pubmed | 7.21e-07 | 15 | 170 | 4 | 19536649 | ||
| Pubmed | Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex. | 7.21e-07 | 15 | 170 | 4 | 27073218 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KRT18 MYO5A DSP POLD2 UBR4 HEATR1 ANKHD1 LDHA TRRAP DDX10 KIF20A RLF S100A8 MDN1 AP2B1 FANCI A2ML1 MACF1 MMS19 PRR14L TANC1 KIF11 | 8.36e-07 | 1353 | 170 | 22 | 29467282 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 8.40e-07 | 104 | 170 | 7 | 31240132 | |
| Pubmed | Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. | 1.14e-06 | 5 | 170 | 3 | 15199141 | |
| Pubmed | 2.27e-06 | 6 | 170 | 3 | 25347706 | ||
| Pubmed | 3.57e-06 | 183 | 170 | 8 | 23956138 | ||
| Pubmed | KRT13 MYO5A ACAD9 PIEZO1 COPE UBR4 HEATR1 DDX10 TUBGCP6 MDN1 ARHGEF10 EHMT2 CLMN SLMAP MACF1 TANC1 ATXN10 DNAJC1 ATM DNA2 TMCC1 PCNT | 3.87e-06 | 1487 | 170 | 22 | 33957083 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GBF1 KRT18 MYO5A DSP COPE UBR4 API5 ANKHD1 LDHA MDN1 AP1B1 AP2B1 FANCI IQCB1 MACF1 MMS19 ATXN10 IQGAP3 KIF11 | 3.90e-06 | 1149 | 170 | 19 | 35446349 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYO5A TTC21A SPTB RNF213 POMT1 ARMC2 TRRAP AHDC1 ADCY3 RLF TLK1 INTS2 PIK3C3 CLMN TBC1D1 ZNF589 MACF1 TANC1 ARHGEF4 HECTD1 TMCC1 PCNT | 3.95e-06 | 1489 | 170 | 22 | 28611215 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | KRT72 KRT18 DSP COPE UBR4 XPO4 LDHA S100A8 MDN1 AP1B1 PABPC1L MMS19 ATXN10 IQGAP3 | 4.03e-06 | 647 | 170 | 14 | 26618866 |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 4.82e-06 | 135 | 170 | 7 | 29859926 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A ACAD9 XPO4 HEATR1 DIPK2A DDX10 FANCD2 MDN1 INTS2 FANCI CEP250 DNAJC1 DNA2 HECTD1 PCNT | 4.98e-06 | 754 | 170 | 15 | 33060197 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GBF1 RNF213 POMT1 MEAK7 FANCD2 MDN1 MROH1 INTS2 FANCI SCARA5 RABGAP1L MACF1 ADGRE5 C5 ATM SGSM3 SLC4A4 CAVIN2 | 5.02e-06 | 1061 | 170 | 18 | 33845483 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 GBF1 KRT18 DSP KRT33B UBR4 XPO4 HEATR1 TRRAP PPP4R3A S100A8 TLK1 AP2B1 PIK3C3 FANCI SLMAP MMS19 ATXN10 POLQ BRF2 | 5.20e-06 | 1284 | 170 | 20 | 17353931 |
| Pubmed | KRT13 KRT18 DSP PNISR PPP4R3A S100A8 TLK1 AP2B1 CEP250 MACF1 ARHGEF4 SLC4A4 | 5.40e-06 | 486 | 170 | 12 | 20936779 | |
| Pubmed | LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. | 6.31e-06 | 8 | 170 | 3 | 29336888 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.39e-06 | 202 | 170 | 8 | 33005030 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NPHP1 ACAD9 TTC21A EI24 XPO4 GIGYF1 HEATR1 PGM3 PPP4R3A POSTN RNF214 TLK1 AP2B1 USH1G TBC1D1 CBY1 RABGAP1L IQCB1 ATXN10 IQGAP3 | 7.90e-06 | 1321 | 170 | 20 | 27173435 |
| Pubmed | 8.54e-06 | 97 | 170 | 6 | 22360420 | ||
| Pubmed | ACAD9 COPE UBR4 RNF213 CAVIN3 ANKHD1 LDHA S100A8 RNF214 AP2B1 ARHGEF10 EHMT2 MACF1 | 9.03e-06 | 601 | 170 | 13 | 33658012 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.05e-05 | 212 | 170 | 8 | 33853758 | |
| Pubmed | 1.22e-05 | 360 | 170 | 10 | 33111431 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.30e-05 | 157 | 170 | 7 | 30686591 | |
| Pubmed | Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. | 1.34e-05 | 10 | 170 | 3 | 26075824 | |
| Pubmed | Cdk12 is essential for embryonic development and the maintenance of genomic stability. | 1.34e-05 | 10 | 170 | 3 | 26658019 | |
| Pubmed | MYO5A ACAD9 PIEZO1 WHAMM HEATR1 API5 ANKHD1 PNISR TRRAP CCNK AHDC1 DDX10 MDN1 INTS2 EHMT2 NFRKB MACF1 TANC1 DNAJC1 IQGAP3 TMCC1 | 1.46e-05 | 1497 | 170 | 21 | 31527615 | |
| Pubmed | 1.62e-05 | 225 | 170 | 8 | 25277244 | ||
| Pubmed | 1.62e-05 | 225 | 170 | 8 | 12168954 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KRT18 ACAD9 TTI2 UBR4 HEATR1 PGM3 DIPK2A DDX10 FANCD2 AP1B1 FANCI MMS19 ATXN10 HECTD1 IQGAP3 KIF11 | 1.70e-05 | 942 | 170 | 16 | 31073040 |
| Pubmed | The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. | 1.84e-05 | 11 | 170 | 3 | 19965384 | |
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 24800743 | ||
| Pubmed | LXR deficiency confers increased protection against visceral Leishmania infection in mice. | 2.38e-05 | 2 | 170 | 2 | 21103366 | |
| Pubmed | Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. | 2.38e-05 | 2 | 170 | 2 | 19933273 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15539633 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26324101 | ||
| Pubmed | Suppression of beta-catenin signaling by liver X receptor ligands. | 2.38e-05 | 2 | 170 | 2 | 18983830 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23185273 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15611369 | ||
| Pubmed | Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas. | 2.38e-05 | 2 | 170 | 2 | 21356276 | |
| Pubmed | LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. | 2.38e-05 | 2 | 170 | 2 | 11149950 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 34799646 | ||
| Pubmed | DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex. | 2.38e-05 | 2 | 170 | 2 | 32269332 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11851872 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16325781 | ||
| Pubmed | Macrophages release plasma membrane-derived particles rich in accessible cholesterol. | 2.38e-05 | 2 | 170 | 2 | 30127022 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26504234 | ||
| Pubmed | FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | 2.38e-05 | 2 | 170 | 2 | 34256011 | |
| Pubmed | Myelin-derived lipids modulate macrophage activity by liver X receptor activation. | 2.38e-05 | 2 | 170 | 2 | 22984598 | |
| Pubmed | FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. | 2.38e-05 | 2 | 170 | 2 | 19561358 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25980575 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19837721 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17391100 | ||
| Pubmed | BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. | 2.38e-05 | 2 | 170 | 2 | 11792716 | |
| Pubmed | Accumulation of foam cells in liver X receptor-deficient mice. | 2.38e-05 | 2 | 170 | 2 | 12196343 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17693624 | ||
| Pubmed | Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum. | 2.38e-05 | 2 | 170 | 2 | 26023184 | |
| Pubmed | Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. | 2.38e-05 | 2 | 170 | 2 | 19717840 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15542845 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33284790 | ||
| Pubmed | Lxrα regulates the androgen response in prostate epithelium. | 2.38e-05 | 2 | 170 | 2 | 22547570 | |
| Pubmed | Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. | 2.38e-05 | 2 | 170 | 2 | 17766241 | |
| Pubmed | The medicinal chemistry of liver X receptor (LXR) modulators. | 2.38e-05 | 2 | 170 | 2 | 24832115 | |
| Pubmed | Improved metabolic control by depletion of Liver X Receptors in mice. | 2.38e-05 | 2 | 170 | 2 | 16876124 | |
| Pubmed | Liver X receptors bridge hepatic lipid metabolism and inflammation. | 2.38e-05 | 2 | 170 | 2 | 22257474 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19380774 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.38e-05 | 2 | 170 | 2 | 23641057 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28636932 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17405904 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27335465 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19487338 | ||
| Pubmed | Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. | 2.38e-05 | 2 | 170 | 2 | 19465922 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17166844 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28912346 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23823481 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24413902 | ||
| Pubmed | Expression and purification of human FANCI and FANCD2 using Escherichia coli cells. | 2.38e-05 | 2 | 170 | 2 | 25168188 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21042792 | ||
| Pubmed | Phospholipase A(2)-modified low-density lipoprotein activates liver X receptor in human macrophages. | 2.38e-05 | 2 | 170 | 2 | 22367754 | |
| Pubmed | Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. | 2.38e-05 | 2 | 170 | 2 | 11546778 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19122149 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15548517 | ||
| Pubmed | Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. | 2.38e-05 | 2 | 170 | 2 | 16973760 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18840761 | ||
| Pubmed | Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. | 2.38e-05 | 2 | 170 | 2 | 17563384 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8031839 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24278431 | ||
| Pubmed | Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. | 2.38e-05 | 2 | 170 | 2 | 23292650 | |
| Interaction | OPALIN interactions | KNTC1 RTTN EI24 XPO4 RNF213 HEATR1 FANCD2 MDN1 MROH1 INTS2 FANCI ADGRE5 ATM | 1.98e-08 | 209 | 166 | 13 | int:OPALIN |
| Interaction | FPR1 interactions | KNTC1 GBF1 ADCK1 TTI2 XPO4 RNF213 PGM3 FANCD2 INTS2 CLMN ATM | 3.82e-08 | 147 | 166 | 11 | int:FPR1 |
| Interaction | UNC93B1 interactions | ACAD9 COPE TTI2 UBR4 EI24 XPO4 RNF213 HEATR1 ANKHD1 FANCD2 MDN1 FANCI ADGRE5 MMS19 DNAJC1 ATM | 3.76e-07 | 417 | 166 | 16 | int:UNC93B1 |
| Interaction | COMTD1 interactions | KNTC1 GBF1 XPO4 HEATR1 PGM3 DIPK2A PPP4R3A FANCD2 INTS2 MMS19 ATXN10 | 8.62e-07 | 200 | 166 | 11 | int:COMTD1 |
| Interaction | CD70 interactions | 1.21e-06 | 166 | 166 | 10 | int:CD70 | |
| Interaction | GPR45 interactions | KNTC1 GBF1 ADCK1 TTI2 XPO4 RNF213 HEATR1 PGM3 FANCD2 MDN1 MROH1 INTS2 ATM | 1.28e-06 | 300 | 166 | 13 | int:GPR45 |
| Interaction | GAN interactions | KRT33B SPTB RTTN RNF213 PARP14 TRRAP PGM3 CBY1 TEKT1 ANKRD36 KIF11 PCNT | 1.30e-06 | 253 | 166 | 12 | int:GAN |
| Interaction | GYPA interactions | KNTC1 GBF1 TTI2 XPO4 INTS2 PIK3C3 RABGAP1L IQCB1 DNAJC1 CREB3 | 1.85e-06 | 174 | 166 | 10 | int:GYPA |
| Interaction | FAM174A interactions | GBF1 RNF213 HEATR1 PARP14 PGM3 FANCD2 ELMO3 MROH1 INTS2 FANCI ATXN10 | 2.61e-06 | 224 | 166 | 11 | int:FAM174A |
| Interaction | ILVBL interactions | 2.91e-06 | 183 | 166 | 10 | int:ILVBL | |
| Interaction | NPTN interactions | KNTC1 GBF1 TTI2 XPO4 RNF213 HEATR1 FANCD2 MDN1 MROH1 MMS19 ATM SGSM3 | 3.46e-06 | 278 | 166 | 12 | int:NPTN |
| Interaction | GPR17 interactions | KNTC1 GBF1 ADCK1 TTI2 XPO4 RNF213 HEATR1 PGM3 FANCD2 MDN1 INTS2 ATM | 4.16e-06 | 283 | 166 | 12 | int:GPR17 |
| Interaction | HLA-B interactions | GBF1 RTTN RNF213 HEATR1 FANCD2 MDN1 MROH1 FANCI MMS19 SGSM3 ARHGEF4 | 4.87e-06 | 239 | 166 | 11 | int:HLA-B |
| Interaction | KRT72 interactions | 8.96e-06 | 59 | 166 | 6 | int:KRT72 | |
| Interaction | XRN1 interactions | VWA5B2 GBF1 POLD2 COPE SMG5 HEATR1 STIL LDHA KIF20A ADGRE5 HECTD1 | 1.00e-05 | 258 | 166 | 11 | int:XRN1 |
| Interaction | TACSTD2 interactions | 1.17e-05 | 129 | 166 | 8 | int:TACSTD2 | |
| Interaction | SCN2B interactions | 1.36e-05 | 95 | 166 | 7 | int:SCN2B | |
| Interaction | TRIM52 interactions | 1.46e-05 | 133 | 166 | 8 | int:TRIM52 | |
| Interaction | CEP152 interactions | 1.80e-05 | 179 | 166 | 9 | int:CEP152 | |
| Interaction | P2RY8 interactions | 1.80e-05 | 179 | 166 | 9 | int:P2RY8 | |
| Interaction | MLNR interactions | 2.05e-05 | 68 | 166 | 6 | int:MLNR | |
| Interaction | CCDC18 interactions | 2.05e-05 | 68 | 166 | 6 | int:CCDC18 | |
| Interaction | GPR182 interactions | KNTC1 GBF1 ADCK1 TTI2 RNF213 HEATR1 DIPK2A FANCD2 MDN1 MROH1 CLMN FANCI MMS19 ATM | 2.54e-05 | 455 | 166 | 14 | int:GPR182 |
| Interaction | VIPR2 interactions | 3.40e-05 | 194 | 166 | 9 | int:VIPR2 | |
| Interaction | DOCK5 interactions | 3.75e-05 | 111 | 166 | 7 | int:DOCK5 | |
| Interaction | CD40 interactions | 4.02e-05 | 153 | 166 | 8 | int:CD40 | |
| Interaction | DES interactions | 5.06e-05 | 158 | 166 | 8 | int:DES | |
| Interaction | IQCB1 interactions | NPHP1 KRT72 KNTC1 KRT18 DSP FANCD2 MROH1 IQCB1 MMS19 ATXN10 HECTD1 IQGAP3 | 5.93e-05 | 370 | 166 | 12 | int:IQCB1 |
| Interaction | BSG interactions | KNTC1 GBF1 SPTB TTI2 XPO4 RNF213 HEATR1 API5 TRRAP FANCD2 MDN1 AP2B1 IQCB1 MMS19 ATXN10 ATM | 6.89e-05 | 631 | 166 | 16 | int:BSG |
| Interaction | CNTROB interactions | 7.16e-05 | 166 | 166 | 8 | int:CNTROB | |
| Interaction | TOP3B interactions | VWA5B2 GBF1 MFHAS1 PIEZO1 SPTB UBR4 RTTN SMG5 ANKHD1 TRRAP LYST AHDC1 TLK1 MDN1 MROH1 FANCI TTLL4 MMS19 TANC1 ARHGEF4 DNA2 HECTD1 IQGAP3 CREB3 PCNT KLHL17 | 1.74e-04 | 1470 | 166 | 26 | int:TOP3B |
| Interaction | EPPK1 interactions | 1.76e-04 | 189 | 166 | 8 | int:EPPK1 | |
| Interaction | UPK2 interactions | 1.78e-04 | 142 | 166 | 7 | int:UPK2 | |
| Interaction | IRAG2 interactions | 1.87e-04 | 14 | 166 | 3 | int:IRAG2 | |
| Interaction | CYP4A22 interactions | 2.01e-04 | 3 | 166 | 2 | int:CYP4A22 | |
| Interaction | FLNB interactions | 2.20e-04 | 304 | 166 | 10 | int:FLNB | |
| Interaction | STK32B interactions | 2.32e-04 | 15 | 166 | 3 | int:STK32B | |
| Interaction | KRT74 interactions | 2.37e-04 | 37 | 166 | 4 | int:KRT74 | |
| Interaction | CEP350 interactions | 2.39e-04 | 149 | 166 | 7 | int:CEP350 | |
| Cytoband | 3q13.33 | 1.88e-04 | 30 | 170 | 3 | 3q13.33 | |
| Cytoband | 11q22-q23 | 2.02e-04 | 6 | 170 | 2 | 11q22-q23 | |
| GeneFamily | Engulfment and cell motility proteins | 1.16e-04 | 3 | 113 | 2 | 543 | |
| GeneFamily | Ankyrin repeat domain containing | 1.40e-04 | 242 | 113 | 8 | 403 | |
| GeneFamily | Cavins | 2.30e-04 | 4 | 113 | 2 | 1326 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.51e-04 | 20 | 113 | 3 | 548 | |
| GeneFamily | Tektins | 3.82e-04 | 5 | 113 | 2 | 949 | |
| GeneFamily | Keratins, type I | 6.95e-04 | 28 | 113 | 3 | 608 | |
| GeneFamily | Transient receptor potential cation channels | 6.95e-04 | 28 | 113 | 3 | 249 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.06e-03 | 8 | 113 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.35e-03 | 9 | 113 | 2 | 1234 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | KNTC1 KRT13 C21orf58 POLD2 STIL DDX10 FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 1.44e-06 | 323 | 170 | 12 | M2156 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 4.42e-06 | 190 | 170 | 9 | M761 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | KNTC1 GBF1 XPO4 RNF213 HEATR1 PARP14 LYST DIPK2A MACF1 POLQ DNA2 | 2.07e-10 | 191 | 170 | 11 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | KNTC1 C21orf58 SPTB STIL FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 PCNT | 2.59e-10 | 195 | 170 | 11 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 2.88e-09 | 187 | 170 | 10 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | KNTC1 C21orf58 RTTN STIL FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 3.91e-09 | 193 | 170 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.11e-09 | 194 | 170 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | NPHP1 ABCA13 C21orf58 POLD2 STIL AP2B1 CLMN FANCI ANKRD36 CFAP46 | 4.11e-09 | 194 | 170 | 10 | 5dffa578149104dda33774361e9e77b227b5f1ce |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.32e-09 | 195 | 170 | 10 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.53e-09 | 196 | 170 | 10 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.53e-09 | 196 | 170 | 10 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.53e-09 | 196 | 170 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.76e-09 | 197 | 170 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | KNTC1 C21orf58 STIL KIF20A FANCD2 FANCI POLQ DNA2 IQGAP3 KIF11 | 4.76e-09 | 197 | 170 | 10 | 8b616cde333bdbc0c591035ad9e4949155866245 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | KNTC1 KRT13 ABCA13 C21orf58 KIF20A FANCD2 FANCI POLQ IQGAP3 KIF11 | 5.00e-09 | 198 | 170 | 10 | f088badb90c6c2d916195f5649eda102119c9ac6 |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | ABCA13 STIL ADCY3 KIF20A FANCD2 S100A8 TANC1 POLQ IQGAP3 KIF11 | 5.25e-09 | 199 | 170 | 10 | e222b90caf45904d8f763574e7b6aac13333df92 |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.94e-09 | 157 | 170 | 9 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-08 | 163 | 170 | 9 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-08 | 169 | 170 | 9 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-08 | 174 | 170 | 9 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-08 | 174 | 170 | 9 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-08 | 179 | 170 | 9 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-08 | 179 | 170 | 9 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-08 | 180 | 170 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-08 | 180 | 170 | 9 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 4.12e-08 | 185 | 170 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-08 | 187 | 170 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-08 | 187 | 170 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.19e-08 | 190 | 170 | 9 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.19e-08 | 190 | 170 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.48e-08 | 195 | 170 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.48e-08 | 195 | 170 | 9 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-08 | 197 | 170 | 9 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-08 | 199 | 170 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.05e-08 | 200 | 170 | 9 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.05e-08 | 200 | 170 | 9 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.05e-08 | 200 | 170 | 9 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-07 | 165 | 170 | 8 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-07 | 167 | 170 | 8 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-07 | 169 | 170 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-07 | 169 | 170 | 8 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-07 | 169 | 170 | 8 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-07 | 175 | 170 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.35e-07 | 178 | 170 | 8 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-07 | 179 | 170 | 8 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-07 | 180 | 170 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 4.94e-07 | 181 | 170 | 8 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-07 | 185 | 170 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.07e-07 | 186 | 170 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-07 | 187 | 170 | 8 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-07 | 129 | 170 | 7 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.85e-07 | 189 | 170 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-07 | 130 | 170 | 7 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-07 | 190 | 170 | 8 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.13e-07 | 190 | 170 | 8 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-07 | 190 | 170 | 8 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.71e-07 | 192 | 170 | 8 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.71e-07 | 192 | 170 | 8 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.71e-07 | 192 | 170 | 8 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-07 | 193 | 170 | 8 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.02e-07 | 193 | 170 | 8 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.34e-07 | 194 | 170 | 8 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.34e-07 | 194 | 170 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 8.67e-07 | 195 | 170 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.67e-07 | 195 | 170 | 8 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.67e-07 | 195 | 170 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.01e-07 | 196 | 170 | 8 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.01e-07 | 196 | 170 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.01e-07 | 196 | 170 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 9.36e-07 | 197 | 170 | 8 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.72e-07 | 198 | 170 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.72e-07 | 198 | 170 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.72e-07 | 198 | 170 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 199 | 170 | 8 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-06 | 199 | 170 | 8 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.01e-06 | 199 | 170 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 199 | 170 | 8 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 199 | 170 | 8 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 199 | 170 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 1.05e-06 | 200 | 170 | 8 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.05e-06 | 200 | 170 | 8 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 200 | 170 | 8 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-06 | 200 | 170 | 8 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.05e-06 | 200 | 170 | 8 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.05e-06 | 200 | 170 | 8 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-06 | 200 | 170 | 8 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.26e-06 | 142 | 170 | 7 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.36e-06 | 156 | 170 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-06 | 163 | 170 | 7 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 163 | 170 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 167 | 170 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 168 | 170 | 7 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-06 | 169 | 170 | 7 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 169 | 170 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 169 | 170 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 171 | 170 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 171 | 170 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 171 | 170 | 7 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 172 | 170 | 7 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 4.67e-06 | 173 | 170 | 7 | 5645a3b1e805c71d5d65fc8e4edc4e13208063fc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 173 | 170 | 7 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| Computational | Genes in the cancer module 68. | 8.00e-05 | 26 | 97 | 4 | MODULE_68 | |
| Computational | Keratin. | 8.00e-05 | 26 | 97 | 4 | MODULE_298 | |
| Disease | Nephronophthisis 1 | 3.15e-05 | 2 | 166 | 2 | C4551979 | |
| Disease | Fanconi anemia | 6.08e-05 | 14 | 166 | 3 | cv:C0015625 | |
| Disease | Bipolar Disorder | VIP ABCA13 POMC LDHA GRM5 ADCY3 ARHGEF10 PIK3C3 SLC18A2 DIXDC1 PCNT | 8.75e-05 | 477 | 166 | 11 | C0005586 |
| Disease | Bone marrow hypocellularity | 1.34e-04 | 18 | 166 | 3 | C1855710 | |
| Disease | periostin measurement | 1.87e-04 | 4 | 166 | 2 | EFO_0020628 | |
| Disease | Primary microcephaly | 2.49e-04 | 22 | 166 | 3 | C0431350 | |
| Disease | progression free survival, metastatic colorectal cancer, response to cetuximab, response to CAPOX-B | 3.11e-04 | 5 | 166 | 2 | EFO_0004920, EFO_0007682, EFO_0007683, EFO_1001480 | |
| Disease | Fanconi Anemia | 3.67e-04 | 25 | 166 | 3 | C0015625 | |
| Disease | Pancytopenia | 4.13e-04 | 26 | 166 | 3 | C0030312 | |
| Disease | Acute monocytic leukemia | 4.13e-04 | 26 | 166 | 3 | C0023465 | |
| Disease | nephronophthisis (is_implicated_in) | 4.65e-04 | 6 | 166 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | X-14939 measurement | 4.65e-04 | 6 | 166 | 2 | EFO_0800747 | |
| Disease | melanoma | 5.32e-04 | 248 | 166 | 7 | C0025202 | |
| Disease | Miller Dieker syndrome | 5.74e-04 | 29 | 166 | 3 | C0265219 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 6.49e-04 | 7 | 166 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 6.49e-04 | 7 | 166 | 2 | cv:C0403553 | |
| Disease | asthma, endometriosis | 8.18e-04 | 74 | 166 | 4 | EFO_0001065, MONDO_0004979 | |
| Disease | Abnormality of radial ray | 8.43e-04 | 33 | 166 | 3 | C4228778 | |
| Disease | female breast cancer (is_implicated_in) | 8.61e-04 | 8 | 166 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | nephronophthisis (implicated_via_orthology) | 1.10e-03 | 9 | 166 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement | 1.10e-03 | 9 | 166 | 2 | EFO_0800275 | |
| Disease | Disorder of eye | 1.31e-03 | 212 | 166 | 6 | C0015397 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.37e-03 | 10 | 166 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.67e-03 | 11 | 166 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | C-C motif chemokine 15 measurement | 1.67e-03 | 11 | 166 | 2 | EFO_0008043 | |
| Disease | hypertension (biomarker_via_orthology) | 1.85e-03 | 227 | 166 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Malignant Head and Neck Neoplasm | 1.96e-03 | 44 | 166 | 3 | C0278996 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.00e-03 | 12 | 166 | 2 | C0403553 | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | N-acetylputrescine measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0800127 | |
| Disease | Ck-beta-8-1 measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0008085 | |
| Disease | Gastric Adenocarcinoma | 2.09e-03 | 45 | 166 | 3 | C0278701 | |
| Disease | Nephronophthisis | 2.36e-03 | 13 | 166 | 2 | C0687120 | |
| Disease | Liver carcinoma | 2.39e-03 | 507 | 166 | 9 | C2239176 | |
| Disease | Leukemia, Myelocytic, Acute | 3.03e-03 | 173 | 166 | 5 | C0023467 | |
| Disease | immature platelet count | 3.07e-03 | 106 | 166 | 4 | EFO_0803544 | |
| Disease | Ciliopathies | 3.51e-03 | 110 | 166 | 4 | C4277690 | |
| Disease | Cholestasis | 3.51e-03 | 110 | 166 | 4 | C0008370 | |
| Disease | leukemia | 3.70e-03 | 55 | 166 | 3 | C0023418 | |
| Disease | Moyamoya Disease | 4.05e-03 | 17 | 166 | 2 | C0026654 | |
| Disease | cancer (implicated_via_orthology) | 4.20e-03 | 268 | 166 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | non-alcoholic steatohepatitis (is_marker_for) | 4.54e-03 | 18 | 166 | 2 | DOID:0080547 (is_marker_for) | |
| Disease | immature platelet measurement | 4.65e-03 | 119 | 166 | 4 | EFO_0803541 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 5.05e-03 | 19 | 166 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | hippuric acid measurement | 5.05e-03 | 19 | 166 | 2 | EFO_0010496 | |
| Disease | Hemorrhage | 5.59e-03 | 20 | 166 | 2 | C0019080 | |
| Disease | X-24309 measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0800872 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLRQEKIDLEALML | 406 | Q495M9 | |
| DIGLLQALTEKMVLV | 251 | Q9BXU7 | |
| AQSSKDILLMEVLVL | 191 | Q86TW2 | |
| DILLMEVLVLAVKQL | 196 | Q86TW2 | |
| SDMLVIEAILALKGL | 421 | O95394 | |
| LQMALTELETLAEKL | 591 | O15013 | |
| MDRLQTALLVVLVLL | 1 | O00626 | |
| LAKIDELRQLELMSS | 321 | Q96N23 | |
| LDTLLSMEIKLRLLD | 686 | Q92556 | |
| SMEIKLRLLDLENIQ | 691 | Q92556 | |
| LEKLDIMIRLASQAN | 336 | P63010 | |
| MKVSEAALSLLVLIL | 1 | O15467 | |
| VTLLEKLASMLETLR | 26 | Q969G5 | |
| QERVTLLDLMIAKIT | 241 | Q9UBB4 | |
| LLKLLVSNNMDGILE | 681 | Q8NEN0 | |
| DIVDGNLKSIMRLVL | 106 | Q155Q3 | |
| MRKELQLSLSVTLLL | 1 | Q9UNA3 | |
| LAGEMDIRNILLKQL | 1146 | A8K2U0 | |
| LLRFGKTIMEEQLVL | 516 | Q9H845 | |
| LSNLEDIMRILAKSL | 331 | P48960 | |
| LRLKVDILLDMLSES | 91 | Q9Y3M2 | |
| RLLQKMIDISLDGFL | 406 | Q9NR80 | |
| MVLERILLQTIKFDL | 141 | O75909 | |
| VNKVMESILLRLNDL | 51 | A6NC57 | |
| ADVLEKLDSLMTLLR | 411 | Q8IYW2 | |
| FLDILLLAKMENGSI | 291 | Q02928 | |
| LKLDQFLTLMIQDRL | 2311 | Q86UQ4 | |
| ESLLIKNNEIMELLS | 986 | A6QL63 | |
| MTVQILLKLDRLDLA | 151 | O14579 | |
| GELQKVILMLLDNLD | 661 | Q96KQ7 | |
| LVALMELKVNGRLDQ | 546 | Q6MZZ7 | |
| DIQLEVLKLLAEMSS | 281 | Q9BZZ5 | |
| LEKLDIMIRLASQAN | 336 | Q10567 | |
| IERLEKILQHSSLML | 1896 | A6QL64 | |
| VVQLIDIMKDLTRLS | 121 | Q5TGY3 | |
| LFSNLVEIRLDAIKM | 566 | A1A5B4 | |
| IRLESLQAEIKMLSD | 246 | Q6ZP65 | |
| VRKMSNAELALLLFI | 146 | Q96KC8 | |
| LLKVAASALNRADLM | 31 | Q53FA7 | |
| SKDILLINLIIEHMI | 421 | Q6IN85 | |
| ETTAMLDLLVIRQLK | 156 | Q6P4D5 | |
| AISILMKDLADELAL | 36 | P00338 | |
| QIALLKTSAIEVMLL | 286 | Q13133 | |
| LQKEIASEIIGLLML | 81 | Q9NVI1 | |
| LEIDLDSMRNLKASL | 306 | P05783 | |
| ITMEIVNKLEAVLLL | 2166 | Q9NU22 | |
| SLMKTQAELLLERLQ | 161 | Q9NPI8 | |
| MVLLLILSVLLLKED | 1 | P41594 | |
| MKTLLELQLEGERQL | 771 | O75420 | |
| LLKQILASRSDLLEM | 146 | Q6P4R8 | |
| MIATQKLLEELLVSL | 261 | Q9H2G9 | |
| DLQLLLELLEKMGLC | 816 | Q9Y4C4 | |
| TGLLMKLLSEQQELR | 71 | Q49AS3 | |
| ENLDSLVNLKVLTLM | 461 | A6NIV6 | |
| RTILEMLLGFLKLQQ | 411 | Q96T76 | |
| NVLKTDLLSSLEMIL | 626 | P52732 | |
| LEIELQSQLSMKAGL | 331 | P13646 | |
| LDIMGLALKLANSLI | 5306 | Q5CZC0 | |
| VKMLDEILLQLSASV | 276 | P49005 | |
| VQAKLGISLEEMLLV | 271 | Q01415 | |
| LVLSELLAIMNKVSE | 141 | Q9H0H0 | |
| ALLLALLLQASMEVR | 11 | P01189 | |
| LEVLRDNMVLAILGK | 601 | Q9UQ05 | |
| MSKQELEAELTLRAL | 1061 | P50748 | |
| AVQLSELLTLPVLMK | 1471 | Q96RT7 | |
| RVQVLAAQLLSDMKL | 161 | Q6P9B6 | |
| KITGMLLEIDNSELL | 566 | Q4VXU2 | |
| IFLKNTVISDLLMIL | 61 | Q9H244 | |
| KLLMFLRDTLAIISD | 606 | Q8NDA8 | |
| KLTLMLLELREKAES | 766 | O95613 | |
| QSELLLVKNEMRLSL | 2031 | O95613 | |
| LGDEKIQIVTQMLEL | 96 | Q9H160 | |
| LEQDLNIMDIKIGLL | 891 | Q86VI3 | |
| LRMFLNELKLLVLTG | 6 | Q86YJ5 | |
| LLLLDKELMETLTSR | 1986 | Q9UPN3 | |
| MVLNLALADLAVLLT | 56 | Q15722 | |
| LREMELELAQTKLQL | 181 | B7ZAP0 | |
| LTLAQLVQKRLMALE | 461 | Q86Y26 | |
| LIENALITQSRLMLL | 141 | Q9Y6A1 | |
| LKANVTDIMLILLVE | 156 | Q460N5 | |
| LQILGQTLKASMREL | 361 | Q16322 | |
| DGIMVKLVVNLLQLS | 1641 | Q13315 | |
| RDLMKTALENLIVLL | 886 | Q9ULT8 | |
| MLLPLKQVLELVSSD | 231 | Q6TDP4 | |
| LKTEQDEITLLLSLM | 66 | Q8NA47 | |
| GSIKEDMVELLLLQN | 236 | P58505 | |
| NLKDSERMQLLLTLA | 196 | Q8NDZ4 | |
| SVSKIIADMLFNLLL | 166 | O14681 | |
| GLINRLIEENKMDLL | 196 | O75417 | |
| SLLVKQLRLSMDIDV | 1301 | P01031 | |
| FLDILLLAKMENGSI | 291 | Q5TCH4 | |
| RALLQAILQTEDMLK | 771 | P15924 | |
| SLTLSLMEKEQRLLV | 1056 | Q9BV73 | |
| REMQKAALELLSLDL | 1451 | Q9BV73 | |
| IAELEMQLLLARLIQ | 481 | Q02318 | |
| ELKGMQLLREILANV | 216 | O60266 | |
| TRLDLEQLLTMETKL | 671 | Q96BJ8 | |
| EQLLTMETKLRLLEL | 676 | Q96BJ8 | |
| LQELLAVLLRMAEQL | 266 | Q9HAW0 | |
| LLLAAELGKMLLERN | 61 | A1A5D9 | |
| VMDKLIQADTLLVLV | 2326 | Q99698 | |
| TKLLLLMAESHQEIL | 231 | Q15051 | |
| LQLESLQELMKALVS | 1126 | Q92538 | |
| KDLQLLGLVAALLMA | 161 | Q8NFN8 | |
| LSQLLPMAEQLLEKI | 1031 | Q9H583 | |
| LLILLPSEKAMVQQL | 416 | Q13206 | |
| VDLLLREMQLLKGLL | 371 | Q6BAA4 | |
| VTVLTLLDKLVNMLD | 56 | O95810 | |
| LLDQLRKLQAMVIEI | 206 | O43889 | |
| QLKIINDLLARSIGM | 946 | P51530 | |
| ELAMLNAVTEDLRLK | 276 | Q6ZMJ2 | |
| QILGDVLLKDRMSLQ | 586 | O15259 | |
| LFLLEDLSQKLESML | 966 | Q9BXW9 | |
| SRELDALLIQKLMEL | 2121 | Q5THK1 | |
| LLKLQSMVDLLEGTL | 116 | Q68BL7 | |
| ILAENLTMVTEFLLL | 21 | Q8NGX6 | |
| DILKRVAANALMSLL | 1856 | Q86VV8 | |
| MLTELEKALNSIIDV | 1 | P05109 | |
| SIQEKLQVLMAEGLL | 641 | Q9UPR3 | |
| ALLKASTIEIMLLET | 301 | P55055 | |
| ISLMDKLLRKENLDL | 651 | Q8NEB9 | |
| QLTLGMLHLKEEELI | 311 | Q96HU1 | |
| AMATSKPDILIILLQ | 1276 | Q9C0D5 | |
| LIKEAEIIQGIMALL | 136 | Q969V4 | |
| ELNMSLTALREKLLE | 371 | Q8WW24 | |
| LEKLQLMLARETLQL | 336 | Q8TF30 | |
| LILNLTQDGIKLMFD | 56 | Q9BSU1 | |
| IRNMTLLVEKLETLD | 191 | Q6UX06 | |
| AIMTERKAAAILALL | 206 | P25100 | |
| VKLLLDMGSDINAQI | 1206 | Q8IWZ3 | |
| DIQDGKILMALLEVL | 61 | Q96JQ2 | |
| KILMALLEVLSGRNL | 66 | Q96JQ2 | |
| KDNSLRRILSLLMEL | 341 | Q8IXR9 | |
| LMLLSEFSLVDKLRI | 1766 | Q63HN8 | |
| LTMEELIQLVAARLA | 591 | Q8ND24 | |
| IIQTDLTMLKLAALE | 211 | Q9UKI8 | |
| LTMDETRKLLLLLES | 236 | Q15468 | |
| LLLIMELLTNLLSKE | 911 | Q9C0E2 | |
| LSVSDKQLTDILLME | 121 | Q19AV6 | |
| TEDTMLELLLRLKHL | 1056 | Q13129 | |
| EARLKILETLKLLMQ | 401 | Q6NXR4 | |
| EELLQVVEAMKTLLL | 561 | O95235 | |
| MLEQKLATLQRLLAI | 181 | Q14BN4 | |
| QMLELLVLEQFLGAL | 76 | Q8NBB4 | |
| KQAMLTLELERSALL | 1126 | Q86TI0 | |
| EALIMTLTQLLALKD | 326 | Q9HBJ7 | |
| ILHTDMLLQRKEELL | 376 | Q8IYF3 | |
| LGKLINILLAVMAVL | 586 | O94876 | |
| EAVRLLILILKNMEG | 106 | P0CL84 | |
| LITLLGNKIVFLDMD | 1156 | P08922 | |
| DLLELIDTRMQLLAA | 1781 | P11277 | |
| ILLQTLELARNLAMI | 221 | Q8IYU4 | |
| LGKSEVLIFLQALLM | 401 | Q8NDW8 | |
| GQQDIEMAILTALLK | 351 | Q7Z4N2 | |
| MLVQALRKALEPALS | 511 | Q8N398 | |
| LLTKMLLTEILLDVT | 336 | Q8TF01 | |
| SLNGVQFMDRLKLLL | 916 | Q9Y6R1 | |
| LNRLKVEELALQSMI | 26 | O75971 | |
| EAVRLLILILKNMEG | 106 | P0CL85 | |
| LQISLGRMLLDILKF | 506 | Q9UL62 | |
| ALKEVSVMNLLLVVL | 826 | Q92508 | |
| MLLENIILLLLATDF | 271 | Q6UX68 | |
| KEVMLENLRNLVSLA | 61 | Q86UQ0 | |
| DTLSMDQRLLKLILQ | 416 | Q15063 | |
| LLTGDKDQLVMLLDQ | 4586 | Q5T4S7 | |
| ISIKGQMIRDLLNLA | 921 | Q14679 | |
| VFLALLLDNMLLTVV | 26 | Q05940 | |
| LLALLVLVKQLMSSA | 76 | Q96AQ2 | |
| SELVMLSLELVKTRL | 2321 | Q9Y4A5 | |
| MDTRNKAQLLVLLTL | 1 | P01282 | |
| QISLGRMLLDILKFL | 506 | Q9UBN4 | |
| ALLLDIMTVAGVQKL | 151 | Q8NBV4 | |
| QELVSLKLALDMEIA | 411 | Q14CN4 | |
| SPLAVNLLEKMLVLD | 281 | P53778 | |
| LEAQMESLKEELLSL | 176 | Q14525 | |
| LVLLNMLDNVDKSIG | 291 | Q6P5S2 | |
| LVEMSEKKALLLNEL | 631 | P32418 | |
| IGAITLNNLLLRKDM | 1696 | Q9Y4I1 |